All stock lists
Amdocs Limited (NASDAQ:DOX)
US · Delayed Price · Currency is USD
Technology · Software - Infrastructure
42.69-0.97 (-2.22%)
Market cap
$4.59B
Insider Score
Health Score
Analyst consensus
Listed since
Jun 19, 1998
Website
Insider Score
––Not scored
DOX Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Financial Health Score
Sound
From DOX’s reported statements · Q2 2026 (trailing 12 months)
Profitability15 / 20
Profitable, but on a thin margin.
- Revenue
- $4.65B
- Net income
- $454.7M
- Net margin
- 9.8%
Leverage15 / 20
Little or no net debt.
- Total debt
- $1.09B
- Cash
- $206.5M
- Net debt / EBITDA
- 1.04x
Liquidity6 / 20
Owes more within a year than it holds to pay it.
- Current assets
- $1.59B
- Current liabilities
- $1.70B
- Current ratio
- 0.94
Cash generation19 / 20
The business funds itself from operations.
- Operating cash flow
- $748.8M
- Free cash flow
- $638.8M
- FCF margin
- 13.7%
Dilution & runway20 / 20
Not funding itself by issuing shares.
- Shares outstanding
- 105.5M
- Share growth (1y)
- -4.7%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
DOX Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 1.17 B | 1.17 B | 1.16 B | 1.15 B | 1.14 B | 1.13 B |
| Revenue Growth (YoY) | 2.66 % | 3.88 % | 4.13 % | -8.99 % | -8.45 % | -9.44 % |
| Cost of Revenue | 707.74 M | 737.91 M | 727.72 M | 720.24 M | 711.15 M | 698.05 M |
| Gross Profit | 467.15 M | 434.07 M | 428.22 M | 429.98 M | 433.29 M | 430.15 M |
| SG&A Expense | 149.25 M | 154.54 M | 113.72 M | 122.17 M | 127.59 M | 134.63 M |
| R&D Expense | 86.37 M | 87.00 M | 81.98 M | 87.86 M | 86.85 M | 81.80 M |
| Operating Expenses | 256.19 M | 241.54 M | 221.53 M | 224.32 M | 230.82 M | 232.42 M |
| Operating Income | 210.96 M | 192.53 M | 206.68 M | 205.66 M | 202.47 M | 197.74 M |
| Pretax Income | 90.46 M | 176.89 M | 195.42 M | 120.78 M | 190.76 M | 189.27 M |
| Tax Provision | 27.26 M | 38.12 M | 36.96 M | 23.67 M | 35.96 M | 25.27 M |
| Net Income | 62.17 M | 137.81 M | 157.57 M | 97.11 M | 154.00 M | 163.24 M |
| EPS (Basic) | 0.59 | 1.29 | 1.45 | 0.89 | 1.39 | 1.46 |
| EPS (Diluted) | 0.59 | 1.28 | 1.45 | 0.88 | 1.39 | 1.45 |
| Shares Outstanding | 105.45 M | 107.09 M | 108.51 M | 109.28 M | 110.61 M | 111.96 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.